News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
721,037 Results
Type
Article (46811)
Company Profile (295)
Press Release (673931)
Multimedia
Podcasts (66)
Webinars (12)
Section
Business (209265)
Career Advice (2189)
Deals (36018)
Drug Delivery (114)
Drug Development (82358)
Employer Resources (191)
FDA (16359)
Job Trends (15251)
News (352645)
Policy (33253)
Tag
Academia (2743)
Academic (2)
Accelerated approval (5)
Adcomms (23)
Allergies (87)
Alliances (50996)
ALS (92)
Alzheimer's disease (1425)
Antibody-drug conjugate (ADC) (131)
Approvals (16358)
Artificial intelligence (275)
Autoimmune disease (22)
Automation (16)
Bankruptcy (366)
Best Places to Work (11826)
BIOSECURE Act (20)
Biosimilars (107)
Biotechnology (201)
Bladder cancer (78)
Brain cancer (27)
Breast cancer (281)
Cancer (2284)
Cardiovascular disease (179)
Career advice (1837)
Career pathing (33)
CAR-T (160)
Cell therapy (443)
Cervical cancer (20)
Clinical research (66713)
Collaboration (861)
Compensation (525)
Complete response letters (21)
COVID-19 (2668)
CRISPR (42)
C-suite (248)
Cystic fibrosis (101)
Data (2208)
Decentralized trials (2)
Denatured (31)
Depression (43)
Diabetes (272)
Diagnostics (6520)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (47)
Drug discovery (123)
Drug pricing (107)
Drug shortages (26)
Duchenne muscular dystrophy (96)
Earnings (87470)
Editorial (39)
Employer branding (25)
Employer resources (161)
Events (115914)
Executive appointments (741)
FDA (17618)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (776)
Gene editing (109)
Generative AI (22)
Gene therapy (318)
GLP-1 (756)
Government (4569)
Grass and pollen (4)
Guidances (59)
Healthcare (19197)
Huntington's disease (25)
IgA nephropathy (29)
Immunology and inflammation (122)
Indications (29)
Infectious disease (2813)
Inflammatory bowel disease (141)
Inflation Reduction Act (10)
Influenza (51)
Intellectual property (98)
Interviews (345)
IPO (16717)
IRA (42)
Job creations (3842)
Job search strategy (1570)
Kidney cancer (10)
Labor market (41)
Layoffs (489)
Leadership (19)
Legal (8069)
Liver cancer (76)
Lung cancer (328)
Lymphoma (154)
Machine learning (7)
Management (62)
Manufacturing (314)
MASH (68)
Medical device (13531)
Medtech (13536)
Mergers & acquisitions (19845)
Metabolic disorders (706)
Multiple sclerosis (82)
NASH (22)
Neurodegenerative disease (93)
Neuropsychiatric disorders (27)
Neuroscience (1975)
NextGen: Class of 2025 (6717)
Non-profit (4650)
Now hiring (40)
Obesity (381)
Opinion (223)
Ovarian cancer (77)
Pain (88)
Pancreatic cancer (84)
Parkinson's disease (152)
Partnered (21)
Patents (236)
Patient recruitment (112)
Peanut (48)
People (59297)
Pharmaceutical (71)
Pharmacy benefit managers (18)
Phase I (20780)
Phase II (29363)
Phase III (21885)
Pipeline (1191)
Policy (143)
Postmarket research (2643)
Preclinical (9066)
Press Release (72)
Prostate cancer (107)
Psychedelics (32)
Radiopharmaceuticals (252)
Rare diseases (386)
Real estate (6228)
Recruiting (72)
Regulatory (22717)
Reports (55)
Research institute (2477)
Resumes & cover letters (374)
Rett syndrome (5)
RNA editing (5)
RSV (44)
Schizophrenia (72)
Series A (137)
Series B (87)
Service/supplier (14)
Sickle cell disease (55)
Special edition (15)
Spinal muscular atrophy (150)
Sponsored (30)
Startups (3779)
State (2)
Stomach cancer (14)
Supply chain (69)
Tariffs (39)
The Weekly (33)
Vaccines (714)
Venture capitalists (43)
Weight loss (253)
Women's health (37)
Worklife (18)
Date
Today (176)
Last 7 days (877)
Last 30 days (2670)
Last 365 days (33403)
2025 (10795)
2024 (35947)
2023 (40860)
2022 (51924)
2021 (56499)
2020 (54898)
2019 (47645)
2018 (35936)
2017 (33085)
2016 (32665)
2015 (38767)
2014 (32375)
2013 (27536)
2012 (29798)
2011 (30535)
2010 (29032)
Location
Africa (793)
Alabama (54)
Alaska (7)
Arizona (240)
Arkansas (14)
Asia (39520)
Australia (6502)
California (6168)
Canada (2016)
China (528)
Colorado (273)
Connecticut (273)
Delaware (147)
Europe (85907)
Florida (912)
Georgia (214)
Hawaii (1)
Idaho (58)
Illinois (551)
India (27)
Indiana (315)
Iowa (11)
Japan (162)
Kansas (106)
Kentucky (25)
Louisiana (11)
Maine (62)
Maryland (902)
Massachusetts (4629)
Michigan (237)
Minnesota (408)
Mississippi (2)
Missouri (82)
Montana (27)
Nebraska (25)
Nevada (64)
New Hampshire (65)
New Jersey (1744)
New Mexico (30)
New York (1763)
North Carolina (1008)
North Dakota (9)
Northern California (2687)
Ohio (205)
Oklahoma (14)
Oregon (34)
Pennsylvania (1382)
Puerto Rico (12)
Rhode Island (33)
South America (1171)
South Carolina (22)
South Dakota (1)
Southern California (2309)
Tennessee (102)
Texas (918)
United States (23418)
Utah (185)
Virginia (146)
Washington D.C. (66)
Washington State (558)
West Virginia (3)
Wisconsin (64)
721,037 Results for "inception sciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Lone Star Bio
Monogram Accepted to NVIDIA Inception Program
Monogram Orthopaedics Inc. today announced it has joined NVIDIA Inception, a program designed to help companies evolve faster through cutting-edge technology and access to the latest technical resources from NVIDIA.
April 11, 2024
·
4 min read
Business
GV20 Therapeutics Joins NVIDIA Inception to Develop AI Models for Drug and Target Discovery
GV20 Therapeutics announced today that it has joined NVIDIA Inception, a program that nurtures startups revolutionizing industries with technological advancements.
March 12, 2024
·
1 min read
CellChorus joins NVIDIA Inception
CellChorus Inc. today announced it has joined NVIDIA Inception, a program designed to nurture startups revolutionizing industries with advancements in artificial intelligence (AI) and data sciences.
July 24, 2023
·
2 min read
Press Releases
AccuStem Sciences, Inc. and EmeritusDX Announce Partnership to Commercialize MSC Test for Lung Cancer Screening
April 29, 2025
·
4 min read
Business
New Jersey’s Life Sciences Scene Continues Expanding Beyond Big Pharma
Known as the home of big-name companies including Johnson & Johnson, New Jersey has become a destination for more and more small and midsize life sciences businesses. Choose New Jersey, Grace Therapeutics and Onyx Equities executives discuss the state’s life sciences scene.
April 10, 2025
·
6 min read
·
Angela Gabriel
Business
BioSig AI Sciences Selected for NVIDIA Inception Partnership Program to Support R&D Collaboration on AI Medical Device Platform for Hospitals
BioSig Technologies, Inc. today announced that its subsidiary BioSig AI Sciences, Inc. (BAIS) was selected to join NVIDIA Inception, a program designed to partner with companies revolutionizing industries with advancements in artificial intelligence (AI) and data sciences.
July 20, 2023
·
4 min read
Lone Star Bio
Inception Fertility Proudly Sponsors the 2023 American Society for Reproductive Medicine’s Congress & Expo
Continuing on its commitment to advance the field of reproductive medicine, Inception Fertility™ (Inception), the largest provider of comprehensive fertility products and services in North America, proudly announces its participation at 2023 ASRM Scientific Congress, taking place October 14-18, 2023, in New Orleans, Louisiana.
October 18, 2023
·
4 min read
Lone Star Bio
Inception Fertility™ Announces 36 Abstracts Accepted, to be Presented at the 2023 ASRM Scientific Congress
Inception Fertility™ (Inception) announces today 36 of abstracts from its clinical network, The Prelude Network® (Prelude), have been accepted by the American Society for Reproductive Medicine (ASRM) to be presented at the 2023 ASRM Scientific Congress, taking place October 14-18, 2023, in New Orleans, Louisiana.
October 16, 2023
·
4 min read
TrialAssure Joins NVIDIA Inception
April 22, 2024
·
2 min read
Press Releases
AccuStem Sciences, Inc. Announces Acquisition of Proprietary MSC Lung Cancer Screening Test
March 19, 2025
·
5 min read
1 of 72,104
Next